BioAdvance Ventures Fund Overview
- Fund Strategy
-
Venture
- Fund Status
-
Liquidated
- Fund Manager
- Quaker Partners
- Size
-
- Vintage
-
2005
- Dry Powder
-
BioAdvance Ventures Fund General Information
Description
BioAdvance Ventures Fund was an early-stage venture capital fund managed by Quaker Partners. The fund was located in Bala Cynwyd, Pennsylvania.
Contact Information
Fund Manager's Location
- 150 Monument Road
- Suite 207
- Bala Cynwyd, PA 19004
- United States
BioAdvance Ventures Fund Investments (5)
BioAdvance Ventures Fund has made a total of 5 investments. Its most recent deal was a with Argintex for . The deal was made on 23-Oct-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Argintex | 23-Oct-2008 | Other Consumer Non-Durables | Startup | |||
| Cellatope | 02-Apr-2007 | Diagnostic Equipment | Startup | |||
| NuPathe | 13-Sep-2006 | Drug Delivery | Product Development | |||
| Immune Control | 01-Jun-2005 | Early Stage VC (Series A) | Drug Discovery | Product Development | ||
| Protez Pharmaceuticals | 17-Jun-2004 | Early Stage VC (Series A) | Pharmaceuticals | Startup |
BioAdvance Ventures Fund Investment Strategy
BioAdvance Ventures Fund Limited Partners (3)
Cephalon is one of BioAdvance Ventures Fund’s 3 limited partners. Its latest Original was on 23-Sep-2004.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Cephalon | Former | 23-Sep-2004 | Original | ||
| GSK | Current | 23-Sep-2004 | Original | ||
| Pension Plan of Independence Blue Cross | Corporate Pension | Former | 23-Sep-2004 | Original |
BioAdvance Ventures Fund Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
BioAdvance Ventures Fund Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
BioAdvance Ventures Fund Benchmark (134)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| DFJ Mercury Venture Partners | 30-Jun-2021 | ||||
| Healthcare Partners Fund II | |||||
| ZenShin Capital Partners Fund | |||||
| BioAdvance Ventures Fund | |||||
| Saints Capital Avalon | |||||
| Amplifier Venture Fund | |||||
| TD Fund II | |||||
| El Dorado Ventures VII | 31-Dec-2023 | ||||
| Westbridge Ventures II | |||||
| Momentum Bridge & Opportunity Fund 1 |
BioAdvance Ventures Fund FAQs
-
What is BioAdvance Ventures Fund?
BioAdvance Ventures Fund was an early-stage venture capital fund managed by Quaker Partners.
-
Who manages BioAdvance Ventures Fund?
BioAdvance Ventures Fund is managed by Quaker Partners.
-
Where is BioAdvance Ventures Fund domiciled?
BioAdvance Ventures Fund is domiciled in United States: Delaware.
-
What is BioAdvance Ventures Fund's size?
BioAdvance Ventures Fund has a size of .
-
What type of fund is BioAdvance Ventures Fund?
The fund type of BioAdvance Ventures Fund is Venture.
-
What is the status of BioAdvance Ventures Fund?
BioAdvance Ventures Fund is liquidated.
-
What has BioAdvance Ventures Fund invested in?
BioAdvance Ventures Fund has made numerous investments in companies like Argintex, Cellatope, and NuPathe within the Consumer Non-Durables, Diagnostic Equipment, and Drug Delivery industries.
-
What has BioAdvance Ventures Fund invested in recently?
BioAdvance Ventures Fund's latest investment was on 23-Oct-2008 in Argintex, a company within the Consumer Non-Durables industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process